Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 86Breast Neoplasms 70Prostatic Neoplasms 34Head and Neck Neoplasms 26Lung Neoplasms 24Colorectal Neoplasms 24Ovarian Neoplasms 22Uterine Cervical Neoplasms 21Endometrial Neoplasms 16Brain Neoplasms 15Rectal Neoplasms 12Pancreatic Neoplasms 11Colonic Neoplasms 11Urinary Bladder Neoplasms 9Melanoma 9Lymphoma 9Leukemia 9Depression 9Stomach Neoplasms 8Pain 8Motor Activity 8Colorectal Neoplasms, Hereditary Nonpolyposis 8Sarcoma 7Oropharyngeal Neoplasms 7Multiple Myeloma 7Hematologic Neoplasms 7COVID-19 7Vulvar Neoplasms 6Health Behavior 6Glioma 6

Interventions

Vincristine 1Surveys and Questionnaires 1Radiotherapy 1Radiosurgery 1Methotrexate 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Genetic Association Studies 1Drug Therapy 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1Chemoradiotherapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Ototoxicity × Surveys and Questionnaires × Clear all
NCT02890030 2020-04-08

The Platinum Study Comparison Group

Indiana University

Completed
102 enrolled
Genitourinary

Ototoxicity, Testicular Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡